Oxford Technology Park feature at the BioEscalator Grow-on Space 2021 event

On Wednesday 23 June 2021, Oxford Technology Park featured at the BioEscalator’s Grow-on Space event, which provided the opportunity for companies based at the BioEscalator to find out more about the space available in Oxfordshire when they’re ready to move on.

The event was delivered via Zoom and alongside Oxford Technology Park, consisted of presentations from:

  • Oxford Science Park
  • Harwell Campus
  • Abingdon Science Park
  • Oxford Business Park
  • Milton Park.

There were also presentations from specialist lab/office space designers, fitters and specialist moving companies, including:

  • Creative Spaces
  • Robin Swailes Design and Development
  • Kaster Labs and OEG Labs
  • Bulb Interiors
  • HRH Logistics.

During Oxford Technology Park’s presentation, Owners and Directors Angus and Lauren Bates introduced the Park, showing the progress on construction of landmark, lab-enabled office Building One and Building Three – the HQ facility for Native Antigen.  

The plans for the Innovation Quarter – 11 two-storey buildings, which will provide highly flexible space to suit the varied needs of technology and science-based occupiers from spin-outs and start-ups to second and third generation businesses that require grow-on space, were also presented.

This generated 1:1 discussions following the event with life science companies who were interested in pre-lets ahead of Landmark Building One being ready this summer.

It was also good to see and hear from the neighbours on their activity in the market. 

The BioEscalator’s Grow-on Space event follows on from its Pitch Battle, which on Wednesday 9 June 2021, saw BioEscalator based companies pitch their innovative biotech solutions addressing some of the biggest medical needs.






The BioEscalator currently houses 13 innovative life science start-up companies developing new therapeutics for a variety of indications. The companies are at different stages in their journey but are all post-seed and pre-series B funding.

Each company gave a six-minute pitch which was judged by members of the BioEscalator Management Team along with Oxford Technology Park and OSI. The companies included:

  • Nucleome Therapeutics
  • Celentyx
  • PepGen
  • Theolytics
  • Exact Sciences Innovation
  • Ochre Bio
  • Exogene
  • OxVax

Categories of the awards during the Pitch Battle included:

  • Best Pitch – Winner of the event
  • Best Speaker
  • Best Video/Graphics
  • Best Scientific Explanation
  • Best Joke
  • Most mentions of the BioEscalator
  • Most likely future unicorn.

Oxford Technology Park were sponsors of the Best Pitch award. All pitches were extremely polished, making it a difficult decision for the judges. Prospering on the day, PepGen, after sharing a fascinating story, managed to secure the title and received a cash prize of £2000.

Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.